Created in 2016 (France), Hemoblast own 5 sister brands and 4472 competing brands. Hemoblast is owned by Biom'Up, listed on the stock exchange of Paris The ISIN, the company's International Securities Identification Number, is FR0013284080. Hemoblast is part of the Medical Devices & Instruments activity sector.
Share price and profitability of the share Biom'Up (Hemoblast)
Buy Biom'Up share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.
Stock market history Biom'Up (Hemoblast)
*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances
past performances do not prejudice future performances
